1. Home
  2. ATAI vs HYB Comparison

ATAI vs HYB Comparison

Compare ATAI & HYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • HYB
  • Stock Information
  • Founded
  • ATAI 2018
  • HYB 1987
  • Country
  • ATAI Germany
  • HYB United States
  • Employees
  • ATAI N/A
  • HYB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • HYB Investment Managers
  • Sector
  • ATAI Health Care
  • HYB Finance
  • Exchange
  • ATAI Nasdaq
  • HYB Nasdaq
  • Market Cap
  • ATAI 214.8M
  • HYB 191.2M
  • IPO Year
  • ATAI 2021
  • HYB 1999
  • Fundamental
  • Price
  • ATAI $1.64
  • HYB $8.34
  • Analyst Decision
  • ATAI Strong Buy
  • HYB
  • Analyst Count
  • ATAI 4
  • HYB 0
  • Target Price
  • ATAI $9.00
  • HYB N/A
  • AVG Volume (30 Days)
  • ATAI 2.4M
  • HYB 39.6K
  • Earning Date
  • ATAI 11-13-2024
  • HYB 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • HYB 6.67%
  • EPS Growth
  • ATAI N/A
  • HYB N/A
  • EPS
  • ATAI N/A
  • HYB N/A
  • Revenue
  • ATAI $331,000.00
  • HYB N/A
  • Revenue This Year
  • ATAI $93.15
  • HYB N/A
  • Revenue Next Year
  • ATAI N/A
  • HYB N/A
  • P/E Ratio
  • ATAI N/A
  • HYB N/A
  • Revenue Growth
  • ATAI N/A
  • HYB N/A
  • 52 Week Low
  • ATAI $1.03
  • HYB $6.23
  • 52 Week High
  • ATAI $2.85
  • HYB $7.41
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 57.43
  • HYB 63.61
  • Support Level
  • ATAI $1.42
  • HYB $8.21
  • Resistance Level
  • ATAI $1.81
  • HYB $8.35
  • Average True Range (ATR)
  • ATAI 0.18
  • HYB 0.06
  • MACD
  • ATAI 0.00
  • HYB 0.01
  • Stochastic Oscillator
  • ATAI 54.47
  • HYB 96.00

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About HYB New America High Income Fund Inc. (The)

New America High Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.

Share on Social Networks: